TURK İLAÇ VE SERUM SANAYİ A.Ş.

Transaction in Own Shares • Jul 19, 2022

Summary Info	PAYLARIN GERİ ALIMI HAKKINDA
Update Notification Flag	Yes
Correction Notification Flag	No
Postponed Notification Flag	No

Company Performs the Buy-Back	TURK İLAÇ VE SERUM SANAYİ A.Ş.
Company Subject to Buy-Back	TURK İLAÇ VE SERUM SANAYİ A.Ş.

Type Of Buy-Back	Within The Frame Of Buy-Back Program
Board Decision Date	08.06.2022
Maximum Number Of Shares To Be Acquired	1.000.000
Total Amount Of The Fund Set Aside For Acqusition	12.000.000

Details of Buy-Back

Code of Share Subject to Buy-back	Transaction Date	Nominal Value of Shares Subject to Transaction (TRY)	Ratio To Capital (%)	Transaction Price (TRY / Unit)	Nominal Value Of Shares Previously Buy-Backed Within The Frame Of The Program (TRY)	Privileges, If Any, Associated With These Shares
B Grubu, TRILC, TRETRLC00022	08.06.2022	50.000	0,03	9,22
B Grubu, TRILC, TRETRLC00022	16.06.2022	100.000	0,06	8,92
B Grubu, TRILC, TRETRLC00022	24.06.2022	100.000	0,06	9,17
B Grubu, TRILC, TRETRLC00022	30.06.2022	100.000	0,06	8,9
B Grubu, TRILC, TRETRLC00022	19.07.2022	650.000	0,4	9,86

Completion of Buy-Back

Code of Share Subject to Buy-back	Starting Date Of Buy-Back Period	Ending Date of Buy- Back Period	The Maximum Price Paid For The Buy-Backed Shares (TRY / Unit)	The Average Price Paid For The Buy-Backed Shares (TRY / Unit)	The Cost-Of Buy-Back Program (TRY)	Source Used in the Buy-Back Process	Total Number Of Buy-Backed Shares	Ratio Of Buy-Backed Shares To Capital (%)
B Grubu, TRILC, TRETRLC00022	08.06.2022	19.07.2022	9,89	9,47	9.588.375,9	ŞİRKET İÇ KAYNAKLARI	1.000.000	0,62

Is the Buy-Back Program Terminated?	Yes

Additional Explanations

Şirketimiz Yönetim Kurulu'nun 08.06.2026 tarihli almış olduğu kararı ile gerçekleştirilen belirlenmiş azami fon miktarı olan 12.000.000 TL ve azami pay adedi olan 1.000.000 adet çerçevesinde;

Şirketimizin kendi paylarında gerçekleştirmiş olduğu toplam 1.000.000 adet payın alınması suretiyle geri alım programı tamamlanmıştır.

Kamuoyuna duyurulur.